PREVIOUS QUESTION:

 

NEXT QUESTION:

 

How can ado-trastuzumab emtansine (Kadcyla) help with treating HER2-positive breast cancer?

ANSWER

Ado-trastuzumab emtansine (Kadcyla), combines the antibody in trastuzumab with a chemotherapy drug. Doctors give it to people with HER2-positive, advanced breast cancer who were already treated with trastuzumab.

SOURCES:

American Cancer Society.

News release, FDA.

Novartis Oncology.

UpToDate: "Adjuvant medical therapy for HER2-positive breast cancer."

BreastCancer.org: "What to Expect When Taking Herceptin."

MedlinePlus: "Docetaxel Injection," "Paclitaxel Injection,"Trastuzumab: Drug information," "Pertuzumab: Drug information."

Reviewed by Melinda Ratini on January 16, 2020

SOURCES:

American Cancer Society.

News release, FDA.

Novartis Oncology.

UpToDate: "Adjuvant medical therapy for HER2-positive breast cancer."

BreastCancer.org: "What to Expect When Taking Herceptin."

MedlinePlus: "Docetaxel Injection," "Paclitaxel Injection,"Trastuzumab: Drug information," "Pertuzumab: Drug information."

Reviewed by Melinda Ratini on January 16, 2020

NEXT QUESTION:

How can lapatinib (Tykerb) help with treating HER2-positive breast cancer?

WAS THIS ANSWER HELPFUL

"ALEXA, ASK WEBMD"

THIS TOOL DOES NOT PROVIDE MEDICAL ADVICE. It is intended for general informational purposes only and does not address individual circumstances. It is not a substitute for professional medical advice, diagnosis or treatment and should not be relied on to make decisions about your health. Never ignore professional medical advice in seeking treatment because of something you have read on the WebMD Site. If you think you may have a medical emergency, immediately call your doctor or dial 911.

    This tool does not provide medical advice. See additional information.

    Other Answers On: